# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Barclays analyst Carter Gould maintains Merck & Co (NYSE:MRK) with a Overweight and lowers the price target from $145 to...
B of A Securities analyst Geoff Meacham maintains Merck & Co (NYSE:MRK) with a Buy and lowers the price target from $150...
Wells Fargo analyst Mohit Bansal maintains Merck & Co (NYSE:MRK) with a Equal-Weight and lowers the price target from $1...
UBS analyst Colin Bristow maintains Merck & Co (NYSE:MRK) with a Buy and lowers the price target from $148 to $142.